Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-13-005809
Filing Date
2013-05-09
Accepted
2013-05-09 16:26:14
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a2215152z424b5.htm 424B5 363773
2 G486654.JPG g486654.jpg GRAPHIC 18908
3 G281369.JPG g281369.jpg GRAPHIC 237913
4 G526115.JPG g526115.jpg GRAPHIC 12878
  Complete submission text file 0001047469-13-005809.txt   736719
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-188407 | Film No.: 13829263
SIC: 2834 Pharmaceutical Preparations